Birmingham's adult obesity rate, Alabama Medicaid's weight-loss exclusion, the published local dose-ladder prices, and the county's low-income shortage designation, each figure sourced.
42.2% of Birmingham adults have obesity, per the CDC's PLACES place-level estimates from the 2023 BRFSS, crude prevalence 1. Jefferson County reads 37.4% in the same release 2, and Alabama's adult rate is 39.2% in the 2023 BRFSS 3.
The city runs 4.8 points above its own county and three points above its state. That gradient, not a superlative, is the claim, and it sets up the two questions that follow: what Alabama Medicaid will pay for, and what a Birmingham clinic actually charges when it publishes a number at all.
Alabama Medicaid's own pharmacy rules exclude weight-loss use specifically: the state lists among coverage exclusions "agents when used for anorexia, weight loss, or weight gain except for those specified by the Alabama Medicaid Agency" (Administrative Code Chapter 16, Pharmaceutical Services) 7. As of January 2026, Alabama is not among the 13 state Medicaid programs covering GLP-1s for obesity under fee-for-service 6.
This is a weight-loss exclusion, not a blanket one. GLP-1s remain covered for type 2 diabetes, including Ozempic and Mounjaro, with prior authorization 7. For a Birmingham adult whose only indication is obesity, the practical consequence is that the price list below is the whole benefit.
Birmingham's market splits cleanly. The city's established programs, Weigh To Wellness, Smart Skin Med Spa, and Infinity Med-I-Spa, publish no GLP-1 prices on their own sites as of Aug 27, 2026. The providers that do publish are edge-of-city entrants quoting "starting at" rates that climb with dose.
Trussville Urgent Care, the only provider in this table with an in-city Birmingham street address on its own page (1960 Gadsden Highway, Suite 108), advertises "starting at $230 for first visit and one month of Semaglutide / Tirzepatide injections" and "starting at $230 a month," with the explicit caveat "Price will vary by dosage" 8. Practice Health, in Irondale rather than Birmingham proper, publishes "Investment in your health starts at $200 per month" for its GLP-1 program, with a second program block listing "starts at $225 per month," a $150 initial medical consultation, and weight-management packages starting at $150 9. RescueMD's Birmingham page is a service-area page with no street address and prices the visit, not the drug: "$250 with a physician and $175 with a nurse practitioner," labs and dietitian support included, medications separate 10.
Astra's national price, stated once: compounded semaglutide from $68 per month and compounded tirzepatide from $118 per month on 12-month plans, $816 and $1,416 annually. It is the same in Birmingham as everywhere else and the same at every dose. On two published numbers, $230 a month is more than three times Astra's $68 flat rate, and unlike a dose-ladder rate it does not move when the dose does.
Birmingham is the rare tier-2 metro with a full academic weight-management program in the city core. UAB Weight Loss Medicine at UAB Hospital-Highlands (1201 11th Ave S, Suite 515) staffs physicians board-certified in obesity medicine plus dietitians and diabetes educators, prescribes GLP-1 and dual-agonist therapies when appropriate, and requires no physician referral 11. UAB's Division of Endocrinology also runs an obesity medicine fellowship, which seeds local specialist density 12.
Against that, HRSA designates the entire low-income population of Jefferson County a primary care shortage area: "LI - Jefferson County," HPSA score 12, designated August 15, 2023, with a 3,482:1 population-to-provider ratio and a 63.7 FTE shortage 5. Three safety-net FQHCs carry active facility designations: Aletheia House (score 24), Alabama Regional Medical Services (22), and Christ Health Center (19) 5.
The gap here is not specialist absence but cost, demand, and wait for exactly the population those shortage numbers describe. That is the lane a licensed telehealth review fills: a posted flat price, medication shipped, and a care team you can message. Alabama-level rules sit on the Alabama GLP-1 hub.
Astra treats patients in Alabama through state-licensed physicians.
Among the Birmingham-area clinics that publish prices at all, compounded semaglutide starts at $200–$230 per month. Trussville Urgent Care (Birmingham 35235) lists semaglutide/tirzepatide injections "starting at $230 a month" and says plainly that price varies by dosage; Practice Health's GLP-1 programs start at $200–$225 per month; RescueMD's Birmingham page charges a $175 (nurse practitioner) or $250 (physician) visit fee with medications billed separately. Most of the city's established programs — Weigh To Wellness, Smart Skin Med Spa, Infinity Med-I-Spa — publish no GLP-1 prices on their own sites (all checked Aug 27, 2026). Astra's price is national: $68/month for semaglutide on a 12-month plan, the same in Birmingham as everywhere else.
Against every Birmingham price we could verify, yes. The local clinics that publish prices start at $200–$230 per month for compounded semaglutide or tirzepatide — and those are "starting at" rates that climb as your dose increases. Astra's price is national and flat: $68/month for semaglutide and $118/month for tirzepatide on 12-month plans ($816 and $1,416 per year), identical in Birmingham and at every dose. There is no Birmingham-specific Astra discount, because Astra doesn't price by city. The honest caveat: several established Birmingham programs publish no prices at all, so they can't be compared.
Because most local programs price compounded GLP-1s on a dose ladder: higher-strength doses cost the clinic more per vial, so the advertised number is the entry dose. Trussville Urgent Care says it directly — injections start "at $230 a month" and "price will vary by dosage." Standard titration moves most patients up from the starting dose within the first few months, which makes the advertised first month typically the cheapest month. Astra's 12-month plans are flat: $68/month semaglutide, $118/month tirzepatide — the same price at every dose.
Not for weight loss. Alabama Medicaid's pharmacy rules exclude "agents when used for anorexia, weight loss, or weight gain" (Alabama Medicaid Administrative Code, Chapter 16), and Alabama is not among the 13 state Medicaid programs that covered GLP-1s for obesity under fee-for-service as of January 2026 (KFF). GLP-1s are covered for type 2 diabetes (Ozempic, Mounjaro) with prior authorization, and state pharmacy materials indicate Wegovy and Zepbound can qualify for specific non-obesity FDA indications — such as cardiovascular risk reduction — under clinical criteria.
Yes. UAB Weight Loss Medicine at UAB Hospital-Highlands (1201 11th Ave S, Suite 515) staffs physicians board-certified in obesity medicine alongside dietitians and diabetes educators, prescribes GLP-1 and dual-agonist therapies when appropriate, and requires no physician referral. UAB's endocrinology division also trains new specialists through an obesity medicine fellowship. It is a genuine in-city option; the practical constraints are academic-center demand, wait times, and cost — which is where a flat-price telehealth plan fits as the comparison.
Last reviewed:
Educational information, not medical advice. Treatment requires evaluation by a licensed physician.